| Drug Name: | Sodium Lactate (72-17-3) |
|---|---|
| PubChem ID: | 23666456 |
| SMILES: | CC(C(=O)[O-])O.[Na+] |
| InchiKey: | NGSFWBMYFKHRBD-UHFFFAOYSA-M |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 112.06 |
| LogP | : | -4.8789 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 3 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 60.36 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Alkalosis | Alanine aminotransferase (P24298) | Depression of 40% in the renal uptake of glutamine with a 38% decrease in renal ammoniagenesis@leading to sodium lactate alkalosis. [ ADR Type 1 ] | The metabolic response of the kidney to acute sodium lactate alkalosis |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|---|
| Hypervolaemia | ADReCS |
| Injection Site Infection | ADReCS |
| Phlebitis | ADReCS |
| Pyrexia | ADReCS |
| Venous Thrombosis | ADReCS |